Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?

Hepatology - United States
doi 10.1002/hep.29575
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Living Donor Liver Transplantation for Hepatocellular Carcinoma

2017English

Value of Live Donor Liver Transplantation Experience in Major Hepatectomy for Hepatocellular Carcinoma

Archives of Surgery
2003English

Recurrence of Hepatocellular Carcinoma Following Deceased Donor Liver Transplantation: Case Series

Hepatoma Research
2020English

Liver Transplantation for Hepatocellular Carcinoma From Living-Donor vs. Deceased Donor

HepatoBiliary Surgery and Nutrition
2016English

Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma in Japan

Hepatoma Research
2018English

Liver Transplantation for Hepatocellular Carcinoma

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2015English

Liver Transplantation for Hepatocellular Carcinoma

Cancer Control
MedicineOncologyHematology
2010English

Potential Role of the Donor in Hepatocellular Carcinoma Recurrence After Liver Transplantation

Liver Transplantation
HepatologyTransplantationSurgery
2015English

Liver Transplantation for Hepatocellular Carcinoma in Asia

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy